PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 34489184-8 2021 Treatment with L-carnitine + Co Q10 ameliorated cognitive impairment and oxidative stress, decreased the brain contents of inflammatory mediators; TNF-alpha, IL-6, and NF-kappabeta elevated AMPK and AKT, as compared to each drug. Carnitine 15-26 protein kinase AMP-activated catalytic subunit alpha 2 Rattus norvegicus 190-194 34489184-0 2021 L-carnitine and Co Q10 ameliorate potassium dichromate -induced acute brain injury in rats targeting AMPK/AKT/NF-kappabeta. Carnitine 0-11 protein kinase AMP-activated catalytic subunit alpha 2 Rattus norvegicus 101-105 34489184-10 2021 L-carnitine + Co Q10 play important role in AMPK/AKT/NF-kappabeta pathway that responsible for their antioxidant and anti-inflammatory effects against PD-induced brain injury in rats. Carnitine 0-11 protein kinase AMP-activated catalytic subunit alpha 2 Rattus norvegicus 44-48 30644033-0 2019 Carnitine Supplementation Attenuates Sunitinib-Induced Inhibition of AMP-Activated Protein Kinase Downstream Signals in Cardiac Tissues. Carnitine 0-9 protein kinase AMP-activated catalytic subunit alpha 2 Rattus norvegicus 69-97